Coverage
-
May 18, 2016
The whistleblower who in April lost a $219 million suit against Abbott Laboratories over allegedly improperly marketed bile duct stents won't get a new trial, a Texas federal judge ruled on Wednesday, finding that nothing in the proceeding led to an unfair trial.
12 other articles on this case.
View all »